Aki Nikolaidis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Aki Nikolaidis has a total of 554 co-authors. Here are the top co-authors by number of shared publications:
- Michael Peter Milham
Child Mind Institute, New York, USA
11 shared publications - Joshua T. Vogelstein
Johns Hopkins University, Baltimore, USA
7 shared publications - Aron Keith Barbey
Deparment of Psychology, University of Notre Dame
5 shared publications - Arthur F. Kramer
University of Illinois
5 shared publications Irene Droney
Child Mind Institute, United States
4 shared publicationsLindsay Alexander
Child Mind Institute, United States
4 shared publications
Latest Publications
- Open Access
- 14 April 2026
- Published by Elsevier in JAACAP Open
- Vol. 4 (4) , 701-712
Negative Online Experiences and Reporting Rates in Youth With Mental Health Conditions
- 14 April 2026
- Published by Elsevier in JAACAP Open
- Vol. 4 (4) , 701-712
Open AccessNegative Online Experiences and Reporting Rates in Youth With Mental Health Conditions
- Open Access
- 31 October 2025
- Published by Organization for Human Brain Mapping in Aperture Neuro
- Vol. 5
Proceedings of the OHBM Hackathon 2023
The OHBM Brainhack 2023 integrated educational innovation, creative expression, and scientific exploration to cultivate a dynamic and inclusive environment for learning and collaboration. The event featured two main components: the Train-Track, which provided structured and flexible hands-on training in a study group setting, and the Hack-Track, where participants engaged in open-source project development. To enhance engagement, the Buddy System facilitated peer support, ensuring newcomers felt welcomed within the Brainhack community. A novel addition to this year’s event was the Rhyming Battle, which encouraged participants to creatively express their experiences through scientific humor and artistic wordplay. Additionally, the introduction of the Mini-Grant Initiative aimed to recognize projects that prioritized open science, diversity, and interdisciplinary collaboration. While this initiative received mixed feedback due to its competitive nature, it provided valuable insights for future iterations. Here we reflect on the successes and lessons learned from Brainhack 2023, underscoring the collective impact of these initiatives.
- 31 October 2025
- Published by Organization for Human Brain Mapping in Aperture Neuro
- Vol. 5
Open AccessProceedings of the OHBM Hackathon 2023
The OHBM Brainhack 2023 integrated educational innovation, creative expression, and scientific exploration to cultivate a dynamic and inclusive environment for learning and collaboration. The event featured two main components: the Train-Track, which provided structured and flexible hands-on training in a study group setting, and the Hack-Track, where participants engaged in open-source project development. To enhance engagement, the Buddy System facilitated peer support, ensuring newcomers felt welcomed within the Brainhack community. A novel addition to this year’s event was the Rhyming Battle, which encouraged participants to creatively express their experiences through scientific humor and artistic wordplay. Additionally, the introduction of the Mini-Grant Initiative aimed to recognize projects that prioritized open science, diversity, and interdisciplinary collaboration. While this initiative received mixed feedback due to its competitive nature, it provided valuable insights for future iterations. Here we reflect on the successes and lessons learned from Brainhack 2023, underscoring the collective impact of these initiatives.
- Top Cited Papers
- 1 June 2025
- Published by MIT Press in Journal of Cognitive Neuroscience
- Vol. 37 (6) , 1023-1034
Beyond Increasing Sample Sizes: Optimizing Effect Sizes in Neuroimaging Research on Individual Differences
Linking neurobiology to relatively stable individual differences in cognition, emotion, motivation, and behavior can require large sample sizes to yield replicable results. Given the nature of between-person research, sample sizes at least in the hundreds are likely to be necessary in most neuroimaging studies of individual differences, regardless of whether they are investigating the whole brain or more focal hypotheses. However, the appropriate sample size depends on the expected effect size. Therefore, we propose four strategies to increase effect sizes in neuroimaging research, which may help to enable the detection of replicable between-person effects in samples in the hundreds rather than the thousands: (1) theoretical matching between neuroimaging tasks and behavioral constructs of interest; (2) increasing the reliability of both neural and psychological measurement; (3) individualization of measures for each participant; and (4) using multivariate approaches with cross-validation instead of univariate approaches. We discuss challenges associated with these methods and highlight strategies for improvements that will help the field to move toward a more robust and accessible neuroscience of individual differences.
- 1 June 2025
- Published by MIT Press in Journal of Cognitive Neuroscience
- Vol. 37 (6) , 1023-1034
Top Cited PapersBeyond Increasing Sample Sizes: Optimizing Effect Sizes in Neuroimaging Research on Individual Differences
Linking neurobiology to relatively stable individual differences in cognition, emotion, motivation, and behavior can require large sample sizes to yield replicable results. Given the nature of between-person research, sample sizes at least in the hundreds are likely to be necessary in most neuroimaging studies of individual differences, regardless of whether they are investigating the whole brain or more focal hypotheses. However, the appropriate sample size depends on the expected effect size. Therefore, we propose four strategies to increase effect sizes in neuroimaging research, which may help to enable the detection of replicable between-person effects in samples in the hundreds rather than the thousands: (1) theoretical matching between neuroimaging tasks and behavioral constructs of interest; (2) increasing the reliability of both neural and psychological measurement; (3) individualization of measures for each participant; and (4) using multivariate approaches with cross-validation instead of univariate approaches. We discuss challenges associated with these methods and highlight strategies for improvements that will help the field to move toward a more robust and accessible neuroscience of individual differences.
- Open Access
- 24 July 2024
- Published by Center for Open Science in OSF Preprints
Beyond Increasing Sample Sizes: Optimizing Effect Sizes in Neuroimaging Research on Individual Differences
Linking neurobiology to relatively stable individual differences in cognition, emotion, motivation, and behavior can require large sample sizes to yield replicable results. Given the nature of between-person research, sample sizes at least in the hundreds are likely to be necessary in most neuroimaging studies of individual differences, regardless of whether they are investigating the whole brain or more focal hypotheses. However, the appropriate sample size depends on the expected effect size. Therefore, we propose four strategies to increase effect sizes in neuroimaging research, which may help to enable the detection of replicable between-person effects in samples in the hundreds rather than the thousands: (1) theoretical matching between neuroimaging tasks and behavioral constructs of interest; (2) increasing the reliability of both neural and psychological measurement; (3) individualization of measures for each participant; and (4) using multivariate approaches with cross-validation instead of univariate approaches. We discuss challenges associated with these methods and highlight strategies for improvements that will help the field to move toward a more robust and accessible neuroscience of individual differences.
- 24 July 2024
- Published by Center for Open Science in OSF Preprints
Open AccessBeyond Increasing Sample Sizes: Optimizing Effect Sizes in Neuroimaging Research on Individual Differences
Linking neurobiology to relatively stable individual differences in cognition, emotion, motivation, and behavior can require large sample sizes to yield replicable results. Given the nature of between-person research, sample sizes at least in the hundreds are likely to be necessary in most neuroimaging studies of individual differences, regardless of whether they are investigating the whole brain or more focal hypotheses. However, the appropriate sample size depends on the expected effect size. Therefore, we propose four strategies to increase effect sizes in neuroimaging research, which may help to enable the detection of replicable between-person effects in samples in the hundreds rather than the thousands: (1) theoretical matching between neuroimaging tasks and behavioral constructs of interest; (2) increasing the reliability of both neural and psychological measurement; (3) individualization of measures for each participant; and (4) using multivariate approaches with cross-validation instead of univariate approaches. We discuss challenges associated with these methods and highlight strategies for improvements that will help the field to move toward a more robust and accessible neuroscience of individual differences.
- Open Access
- 14 February 2023
- Published by Springer Nature in Molecular Autism
- Vol. 14 (1) , 1-17
CRISIS AFAR: an international collaborative study of the impact of the COVID-19 pandemic on mental health and service access in youth with autism and neurodevelopmental conditions
Background: Heterogeneous mental health outcomes during the COVID-19 pandemic are documented in the general population. Such heterogeneity has not been systematically assessed in youth with autism spectrum disorder (ASD) and related neurodevelopmental disorders (NDD). To identify distinct patterns of the pandemic impact and their predictors in ASD/NDD youth, we focused on pandemic-related changes in symptoms and access to services. Methods: Using a naturalistic observational design, we assessed parent responses on the Coronavirus Health and Impact Survey Initiative (CRISIS) Adapted For Autism and Related neurodevelopmental conditions (AFAR). Cross-sectional AFAR data were aggregated across 14 European and North American sites yielding a clinically well-characterized sample of N = 1275 individuals with ASD/NDD (age = 11.0 ± 3.6 years; n females = 277). To identify subgroups with differential outcomes, we applied hierarchical clustering across eleven variables measuring changes in symptoms and access to services. Then, random forest classification assessed the importance of socio-demographics, pre-pandemic service rates, clinical severity of ASD-associated symptoms, and COVID-19 pandemic experiences/environments in predicting the outcome subgroups. Results: Clustering revealed four subgroups. One subgroup—broad symptom worsening only (20%)—included youth with worsening across a range of symptoms but with service disruptions similar to the average of the aggregate sample. The other three subgroups were, relatively, clinically stable but differed in service access: primarily modified services (23%), primarily lost services (6%), and average services/symptom changes (53%). Distinct combinations of a set of pre-pandemic services, pandemic environment (e.g., COVID-19 new cases, restrictions), experiences (e.g., COVID-19 Worries), and age predicted each outcome subgroup. Limitations: Notable limitations of the study are its cross-sectional nature and focus on the first six months of the pandemic. Conclusions: Concomitantly assessing variation in changes of symptoms and service access during the first phase of the pandemic revealed differential outcome profiles in ASD/NDD youth. Subgroups were characterized by distinct prediction patterns across a set of pre- and pandemic-related experiences/contexts. Results may inform recovery efforts and preparedness in future crises; they also underscore the critical value of international data-sharing and collaborations to address the needs of those most vulnerable in times of crisis.
- 14 February 2023
- Published by Springer Nature in Molecular Autism
- Vol. 14 (1) , 1-17
Open AccessCRISIS AFAR: an international collaborative study of the impact of the COVID-19 pandemic on mental health and service access in youth with autism and neurodevelopmental conditions
Background: Heterogeneous mental health outcomes during the COVID-19 pandemic are documented in the general population. Such heterogeneity has not been systematically assessed in youth with autism spectrum disorder (ASD) and related neurodevelopmental disorders (NDD). To identify distinct patterns of the pandemic impact and their predictors in ASD/NDD youth, we focused on pandemic-related changes in symptoms and access to services. Methods: Using a naturalistic observational design, we assessed parent responses on the Coronavirus Health and Impact Survey Initiative (CRISIS) Adapted For Autism and Related neurodevelopmental conditions (AFAR). Cross-sectional AFAR data were aggregated across 14 European and North American sites yielding a clinically well-characterized sample of N = 1275 individuals with ASD/NDD (age = 11.0 ± 3.6 years; n females = 277). To identify subgroups with differential outcomes, we applied hierarchical clustering across eleven variables measuring changes in symptoms and access to services. Then, random forest classification assessed the importance of socio-demographics, pre-pandemic service rates, clinical severity of ASD-associated symptoms, and COVID-19 pandemic experiences/environments in predicting the outcome subgroups. Results: Clustering revealed four subgroups. One subgroup—broad symptom worsening only (20%)—included youth with worsening across a range of symptoms but with service disruptions similar to the average of the aggregate sample. The other three subgroups were, relatively, clinically stable but differed in service access: primarily modified services (23%), primarily lost services (6%), and average services/symptom changes (53%). Distinct combinations of a set of pre-pandemic services, pandemic environment (e.g., COVID-19 new cases, restrictions), experiences (e.g., COVID-19 Worries), and age predicted each outcome subgroup. Limitations: Notable limitations of the study are its cross-sectional nature and focus on the first six months of the pandemic. Conclusions: Concomitantly assessing variation in changes of symptoms and service access during the first phase of the pandemic revealed differential outcome profiles in ASD/NDD youth. Subgroups were characterized by distinct prediction patterns across a set of pre- and pandemic-related experiences/contexts. Results may inform recovery efforts and preparedness in future crises; they also underscore the critical value of international data-sharing and collaborations to address the needs of those most vulnerable in times of crisis.
- Open Access
- 5 December 2022
- Published by Cambridge University Press (CUP) in Development and Psychopathology
- Vol. 35 (3) , 1570
Heterogeneity in caregiving-related early adversity: Creating stable dimensions and subtypes – CORRIGENDUM
- 5 December 2022
- Published by Cambridge University Press (CUP) in Development and Psychopathology
- Vol. 35 (3) , 1570
Open AccessHeterogeneity in caregiving-related early adversity: Creating stable dimensions and subtypes – CORRIGENDUM
- Open Access
- 29 July 2022
- Published by Springer Nature in Research Square
Suboptimal phenotypic reliability impedes reproducible human neuroscience
Biomarkers of behavior and psychiatric illness for cognitive and clinical neuroscience remain out of reach1–4. Suboptimal reliability of biological measurements, such as functional magnetic resonance imaging (fMRI), is increasingly cited as a primary culprit for discouragingly large sample size requirements and poor reproducibility of brain-based biomarker discovery1,5–7. In response, steps are being taken towards optimizing MRI reliability and increasing sample sizes8–11, though this will not be enough. Optimizing biological measurement reliability and increasing sample sizes are necessary but insufficient steps for biomarker discovery; this focus has overlooked the ‘other side of the equation’ - the reliability of clinical and cognitive assessments - which are often suboptimal or unassessed. Through a combination of simulation analysis and empirical studies using neuroimaging data, we demonstrate that the joint reliability of both biological and clinical/cognitive phenotypic measurements must be optimized in order to ensure biomarkers are reproducible and accurate. Even with best-case scenario high reliability neuroimaging measurements and large sample sizes, we show that suboptimal reliability of phenotypic data (i.e., clinical diagnosis, behavioral and cognitive measurements) will continue to impede meaningful biomarker discovery for the field. Improving reliability through development of novel assessments of phenotypic variation is needed, but it is not the sole solution. We emphasize the potential to improve the reliability of established phenotypic methods through aggregation across multiple raters and/or measurements12–15, which is becoming increasingly feasible with recent innovations in data acquisition (e.g., web- and smart-phone-based administration, ecological momentary assessment, burst sampling, wearable devices, multimodal recordings)16–20. We demonstrate that such aggregation can achieve better biomarker discovery for a fraction of the cost engendered by large-scale samples. Although the current study has been motivated by ongoing developments in neuroimaging, the prioritization of reliable phenotyping will revolutionize neurobiological and clinical endeavors that are focused on brain and behavior.
- 29 July 2022
- Published by Springer Nature in Research Square
Open AccessSuboptimal phenotypic reliability impedes reproducible human neuroscience
Biomarkers of behavior and psychiatric illness for cognitive and clinical neuroscience remain out of reach1–4. Suboptimal reliability of biological measurements, such as functional magnetic resonance imaging (fMRI), is increasingly cited as a primary culprit for discouragingly large sample size requirements and poor reproducibility of brain-based biomarker discovery1,5–7. In response, steps are being taken towards optimizing MRI reliability and increasing sample sizes8–11, though this will not be enough. Optimizing biological measurement reliability and increasing sample sizes are necessary but insufficient steps for biomarker discovery; this focus has overlooked the ‘other side of the equation’ - the reliability of clinical and cognitive assessments - which are often suboptimal or unassessed. Through a combination of simulation analysis and empirical studies using neuroimaging data, we demonstrate that the joint reliability of both biological and clinical/cognitive phenotypic measurements must be optimized in order to ensure biomarkers are reproducible and accurate. Even with best-case scenario high reliability neuroimaging measurements and large sample sizes, we show that suboptimal reliability of phenotypic data (i.e., clinical diagnosis, behavioral and cognitive measurements) will continue to impede meaningful biomarker discovery for the field. Improving reliability through development of novel assessments of phenotypic variation is needed, but it is not the sole solution. We emphasize the potential to improve the reliability of established phenotypic methods through aggregation across multiple raters and/or measurements12–15, which is becoming increasingly feasible with recent innovations in data acquisition (e.g., web- and smart-phone-based administration, ecological momentary assessment, burst sampling, wearable devices, multimodal recordings)16–20. We demonstrate that such aggregation can achieve better biomarker discovery for a fraction of the cost engendered by large-scale samples. Although the current study has been motivated by ongoing developments in neuroimaging, the prioritization of reliable phenotyping will revolutionize neurobiological and clinical endeavors that are focused on brain and behavior.
- Open Access
Suboptimal phenotypic reliability impedes reproducible human neuroscience
Summary Paragraph: Biomarkers of behavior and psychiatric illness for cognitive and clinical neuroscience remain out of reach 1–4 . Suboptimal reliability of biological measurements, such as functional magnetic resonance imaging (fMRI), is increasingly cited as a primary culprit for discouragingly large sample size requirements and poor reproducibility of brain-based biomarker discovery 1,5–7 . In response, steps are being taken towards optimizing MRI reliability and increasing sample sizes 8–11 , though this will not be enough. Optimizing biological measurement reliability and increasing sample sizes are necessary but insufficient steps for biomarker discovery; this focus has overlooked the ‘other side of the equation’ - the reliability of clinical and cognitive assessments - which are often suboptimal or unassessed. Through a combination of simulation analysis and empirical studies using neuroimaging data, we demonstrate that the joint reliability of both biological and clinical/cognitive phenotypic measurements must be optimized in order to ensure biomarkers are reproducible and accurate. Even with best-case scenario high reliability neuroimaging measurements and large sample sizes, we show that suboptimal reliability of phenotypic data (i.e., clinical diagnosis, behavioral and cognitive measurements) will continue to impede meaningful biomarker discovery for the field. Improving reliability through development of novel assessments of phenotypic variation is needed, but it is not the sole solution. We emphasize the potential to improve the reliability of established phenotypic methods through aggregation across multiple raters and/or measurements 12–15 , which is becoming increasingly feasible with recent innovations in data acquisition (e.g., web- and smart-phone-based administration, ecological momentary assessment, burst sampling, wearable devices, multimodal recordings) 16–20 . We demonstrate that such aggregation can achieve better biomarker discovery for a fraction of the cost engendered by large-scale samples. Although the current study has been motivated by ongoing developments in neuroimaging, the prioritization of reliable phenotyping will revolutionize neurobiological and clinical endeavors that are focused on brain and behavior.
Open AccessSuboptimal phenotypic reliability impedes reproducible human neuroscience
Summary Paragraph: Biomarkers of behavior and psychiatric illness for cognitive and clinical neuroscience remain out of reach 1–4 . Suboptimal reliability of biological measurements, such as functional magnetic resonance imaging (fMRI), is increasingly cited as a primary culprit for discouragingly large sample size requirements and poor reproducibility of brain-based biomarker discovery 1,5–7 . In response, steps are being taken towards optimizing MRI reliability and increasing sample sizes 8–11 , though this will not be enough. Optimizing biological measurement reliability and increasing sample sizes are necessary but insufficient steps for biomarker discovery; this focus has overlooked the ‘other side of the equation’ - the reliability of clinical and cognitive assessments - which are often suboptimal or unassessed. Through a combination of simulation analysis and empirical studies using neuroimaging data, we demonstrate that the joint reliability of both biological and clinical/cognitive phenotypic measurements must be optimized in order to ensure biomarkers are reproducible and accurate. Even with best-case scenario high reliability neuroimaging measurements and large sample sizes, we show that suboptimal reliability of phenotypic data (i.e., clinical diagnosis, behavioral and cognitive measurements) will continue to impede meaningful biomarker discovery for the field. Improving reliability through development of novel assessments of phenotypic variation is needed, but it is not the sole solution. We emphasize the potential to improve the reliability of established phenotypic methods through aggregation across multiple raters and/or measurements 12–15 , which is becoming increasingly feasible with recent innovations in data acquisition (e.g., web- and smart-phone-based administration, ecological momentary assessment, burst sampling, wearable devices, multimodal recordings) 16–20 . We demonstrate that such aggregation can achieve better biomarker discovery for a fraction of the cost engendered by large-scale samples. Although the current study has been motivated by ongoing developments in neuroimaging, the prioritization of reliable phenotyping will revolutionize neurobiological and clinical endeavors that are focused on brain and behavior.
- Open Access
- 23 March 2022
- Published by Elsevier in Developmental Cognitive Neuroscience
- Vol. 54, 101101
Frontal corticostriatal functional connectivity reveals task positive and negative network dysregulation in relation to ADHD, sex, and inhibitory control
- 23 March 2022
- Published by Elsevier in Developmental Cognitive Neuroscience
- Vol. 54, 101101
Open AccessFrontal corticostriatal functional connectivity reveals task positive and negative network dysregulation in relation to ADHD, sex, and inhibitory control
- 22 March 2022
- Published by Cambridge University Press (CUP) in Development and Psychopathology
- Vol. 34 (2) , 621-634
Heterogeneity in caregiving-related early adversity: Creating stable dimensions and subtypes
Early psychosocial adversities exist at many levels, including caregiving-related, extrafamilial, and sociodemographic, which despite their high interrelatedness may have unique impacts on development. In this paper, we focus on caregiving-related early adversities (crEAs) and parse the heterogeneity of crEAs via data reduction techniques that identify experiential cooccurrences. Using network science, we characterized crEA cooccurrences to represent the comorbidity of crEA experiences across a sample of school-age children (n = 258; 6–12 years old) with a history of crEAs. crEA dimensions (variable level) and crEA subtypes (subject level) were identified using parallel factor analysis/principal component analysis and graph-based Louvain community detection. Bagging enhancement with cross-validation provided estimates of robustness. These data-driven dimensions/subtypes showed evidence of stability, transcended traditional sociolegally defined groups, were more homogenous than sociolegally defined groups, and reduced statistical correlations with sociodemographic factors. Finally, random forests showed both unique and common predictive importance of the crEA dimensions/subtypes for childhood mental health symptoms and academic skills. These data-driven outcomes provide additional tools and recommendations for crEA data reduction to inform precision medicine efforts in this area.
- 22 March 2022
- Published by Cambridge University Press (CUP) in Development and Psychopathology
- Vol. 34 (2) , 621-634
Heterogeneity in caregiving-related early adversity: Creating stable dimensions and subtypes
Early psychosocial adversities exist at many levels, including caregiving-related, extrafamilial, and sociodemographic, which despite their high interrelatedness may have unique impacts on development. In this paper, we focus on caregiving-related early adversities (crEAs) and parse the heterogeneity of crEAs via data reduction techniques that identify experiential cooccurrences. Using network science, we characterized crEA cooccurrences to represent the comorbidity of crEA experiences across a sample of school-age children (n = 258; 6–12 years old) with a history of crEAs. crEA dimensions (variable level) and crEA subtypes (subject level) were identified using parallel factor analysis/principal component analysis and graph-based Louvain community detection. Bagging enhancement with cross-validation provided estimates of robustness. These data-driven dimensions/subtypes showed evidence of stability, transcended traditional sociolegally defined groups, were more homogenous than sociolegally defined groups, and reduced statistical correlations with sociodemographic factors. Finally, random forests showed both unique and common predictive importance of the crEA dimensions/subtypes for childhood mental health symptoms and academic skills. These data-driven outcomes provide additional tools and recommendations for crEA data reduction to inform precision medicine efforts in this area.